Oriola Corporation
Orionintie 5, Espoo, 02200, Finland
Overview
Oriola-KD has a solid position in consumer and services business in the pharmaceutical markets in Sweden, Finland and Baltic countries. Oriola-KD offers expert advice on health and wellbeing and an extensive and high-quality selection of products in its own pharmacies. To healthcare operators, Oriola-KD provides wide service offering covering pharmaceutical distribution, branded products and other tailored services. Oriola-KD unites consumers and pharmaceutical companies in a unique way. Oriola-KD provides pharmaceutical companies an effective access to markets and improves consumers' wellbeing by ensuring that pharmaceuticals, health products and services are delivered in a safe and customer-friendly manner. Oriola-KD’s net sales for continuing operations in 2015 were approximately EUR 1.6 billion.
- Total investments
- 2
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 7
Sector focus
- Health Care
- Medical
- Pharmaceutical
Investment portfolio
- Doktor.se
Participated · Equity · May 2021
Doktor.se operates a digital healthcare platform that allows patients to receive medical advice and treatment online, complemented by physical care when needed. The company is focusing on international growth and has publicly stated a goal of becoming the largest player in the German market. Management is also preparing the business for an IPO, targeting a listing in 2026. To support these ambitions, Doktor.se recently raised new capital while simultaneously developing an additional growth vertical that will require some self-funding. The shareholder register includes high-profile backers such as Evolution Gaming founder Jens von Bahr (via Jovb Investments AB), Anicura founder Peter Dahlberg, and Chinese technology giant Tencent. The firm is currently contending with a dispute involving Region Stockholm, described by the CEO as “infected,” but maintains that the fresh capital will primarily be used for overseas expansion. No specific revenue or user metrics were disclosed in the article.